Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AXXZIA is a Japanese cosmetics and wellness company that specializes in the development and sale of premium skincare products and beauty supplements. Founded in 2011, the company focuses on the "Asian Beauty" concept, blending advanced Japanese manufacturing quality with research into skin aging and glycation. Its flagship brand, AGtheory, specifically targets the effects of glycation on the skin, while the AXXZIA brand offers professional-grade eye care and facial treatments. The company operates a multi-channel distribution model, serving high-end beauty salons and retail outlets, with a significant market presence in mainland China. AXXZIA is publicly traded on the Tokyo Stock Exchange and continues to expand its portfolio through internal R&D and strategic marketing in the global luxury beauty sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AXXZIA.